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Abstract
We report the first de novo sequence assembly and analysis of the genome of Testudinid
herpesvirus 3 (TeHV3), one of the most pathogenic chelonian herpesviruses. The genome
of TeHV3 is at least 150,080 nucleotides long, is arranged in a type D configuration and
comprises at least 102 open reading frames extensively co-linear with those of Human
herpesvirus 1. Consistently, the phylogenetic analysis positions TeHV3 among the Alpha-
herpesvirinae, closely associated with Chelonid herpesvirus 5, a Scutavirus. To date,
there has been limited genetic characterization of TeHVs and a resolution beyond the
genotype was not feasible because of the lack of informative DNA sequences. To exem-
plify the potential benefits of the novel genomic information provided by this first whole
genome analysis, we selected the glycoprotein B (gB) gene, for detailed comparison
among different TeHV3 isolates. The rationale for selecting gB is that it encodes for a well-
conserved protein among herpesviruses but is coupled with a relevant antigenicity and is
consequently prone to accumulate single nucleotide polymorphisms. These features were
considered critical for an ideal phylogenetic marker to investigate the potential existence
of distinct TeHV3 genogroups and their associated pathology. Fifteen captive tortoises
presumptively diagnosed to be infected with TeHVs or carrying compatible lesions on the
basis of either the presence of intranuclear inclusions (presumptively infected) and/or
diphtheronecrotic stomatitis-glossitis or pneumonia (compatible lesions) were selected for
the study. Viral isolation, TeHV identification, phylogenetic analysis and pathological char-
acterization of the associated lesions, were performed. Our results revealed 1) the exis-
tence of at least two distinct TeHV3 genogroups apparently associated with different
pathologies in tortoises and 2) the first evidence for a putative homologous recombination
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event having occurred in a chelonian herpesvirus. This novel information is not only funda-
mental for the genetic characterization of this virus but is also critical to lay the groundwork
for an improved understanding of host-pathogen interactions in chelonians and contribute
to tortoise conservation.
Introduction
Herpesviruses have been reported as significant pathogens of snakes [1, 2], lizards [3–10] and
alligators [11, 12], however, more herpesviruses have been detected in chelonians than in any
other reptilian taxa [13]. Presently, chelonian herpesviruses have been detected and/or isolated
from both turtles and tortoises [14]. The first detection of a chelonian herpesvirus dates back
to the mid 70’s with the discovery of Chelonid herpesvirus 1 (ChHV1), known as “Gray patch
disease-associated herpesvirus”. The disease consisted in a multifocal to coalescent necrotizing
and ulcerative dermatitis observed mainly in young green turtles (Chelonia mydas) [15]. Chelo-
nid herpesvirus 2 and 3 (ChHV2, 3) were detected in fresh water turtles and more specifically
in Pacific pond turtles (Clemmys marmorata-ChHV2) [16] and in painted turtles (Chrysemis
picta-ChHV3) [17] with necrotizing hepatitis. Chelonid herpesvirus 4 (ChHV4) was detected in
Argentine tortoises (Geochelone chilensis-ChHV4) with glossitis, rhinitis and pharyngitis [18].
Additional four herpesviruses were either detected or isolated from tortoises and were named
Testudinid herpesviruses (TeHV1, 2, 3 and 4). TeHV1, 2 and 3 were associated with pathology
mainly in tortoises of the genus Testudo (TeHV1 and 3) and in desert tortoises (Gopherus agas-
sizii) (TeHV2) [14], whereas TeHV4 was detected in a clinically healthy bowsprit tortoise
(Chersina angulata) [14, 19–21]. Chelonid herpesvirus 5 and 6 (ChHV5, 6) are two other sea
turtle herpesviruses associated with a debilitating neoplastic disease called fibropapillomatosis
(mainly in green and loggerhead-Caretta caretta-sea turtles) and with a multisystemic disease
(in green turtles), respectively [22–25]. Two additional herpesviruses have been discovered in
sea turtles and have been named loggerhead genital herpesvirus and the loggerhead cutaneous
herpesvirus and they are responsible for multisystemic lesions in loggerhead sea turtles [13]. In
the last few years an increasing number of novel herpesviruses have been detected in fresh
water turtles. These include a herpesvirus infecting the Australian Krefft’s river turtles (Emy-
dura macquarii kreftii) associated with proliferative and ulcerative tegument lesions [26] and
Pelomedusid herpesvirus 1 in a clinically healthy West African mud turtle (Pelusios castaneous)
[27]. Emydid herpesvirus 1 is a novel chelonian herpesvirus detected in an eastern river cooter
(Pseudemys concinna concinna) with viral inclusions in the hepatocytes [28] and in both dis-
eased (with pneumonia, hepatitis and splenitis) and clinically healthy northern map turtles
(Graptmeys geographica) along with asymptomatic painted turtles [29]. Glyptemis herpesvirus
1 and Glyptemys herpesvirus 2 were recently detected in asymptomatic bog (Glyptemis muhlen-
bergii) and wood turtles (Glyptemis insculpta), respectively, whereas Emydid herpesvirus 2 was
found in bog turtles and in a spotted turtle [30]. At least two herpesviruses have been detected
in box turtles. Terrapene herpesvirus 1 was detected in captive eastern box turtles (Terrapene
carolina carolina) with stomatitis and glossitis [31], whereas Terrapene herpesvirus 2 was
recently identified in an eastern box turtle coinfected with a spirorchid trematode and with
papillomatous growths [32].
Despite the existence of all the chelonian herpesviruses described above, to date the only
genome sequenced is that of ChHV5, a Scutavirus [22]. Only a few hundred nucleotides (nt) of
DNA sequence belonging to the DNA polymerase (DNApol) gene have been determined for
TeHV3 genome and host-pathogen interaction
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other herpesviruses infecting reptiles [33], accounting for less than 0.01% of their entire pre-
dicted genomes. These short sequences have been used to unravel the phylogenetic relatedness
of reptilian herpesviruses. However, the relatively high conservation of the DNApol gene
among herpesviruses, and more specifically of the selected PCR-amplified-region, has ham-
pered any higher resolution regarding diversity of these viruses beyond the genotype.
Testudinid herpesviruses are important pathogens that have been detected in the chelonian
family Testudinidae (tortoises) [14, 19–21]. Of the three genotypes, associated with obvious
pathology, TeHV1 has been detected most frequently in Horsfield’s tortoises (Testudo-Agryo-
nemis horsfieldii) having stomatitis and glossitis [14]. TeHV2 has been identified in North
American desert tortoises [20, 21]. Severe stomatitis, glossitis and pneumonia have been
observed in a TeHV2-infected captive desert tortoise along with pneumonia [21]. TeHV2 has
been shown to serologically cross-react by ELISA with TeHV3 suggesting the existence of simi-
lar antigenic epitopes in the two distinct genotypes [20, 21]. Consistently, the partial sequence
of the TeHV2 ribonucleotide reductase gene (large subunit), a conserved gene in herpesviruses,
shared 79% identity with the homologous TeHV3 gene [21]. TeHV3 is considered the most
pathogenic of the known TeHVs and it has been detected in several species of tortoises associ-
ated with stomatitis and glossitis although it appears to be overrepresented in Greek tortoises
(Testudo graeca) [14]. The pathology of TeHV3 has been thoroughly characterized in a trans-
mission study in Greek tortoises infected with the type-strain 1976/98 with the virus inducing
a disease whose severity was viral-load-dependent [34]. The classic clinical signs associated
with the disease including stomatitis, mono- and bilateral recurrent conjunctivitis and oral dis-
charge were reproduced in the experimentally infected tortoises [34]. In this study, the virus
showed prominent neurotropism and indirect evidence of latency. Furthermore the severity of
the disease appears to vary with the species of tortoise infected. For instance, TeHV3 infection
in the Greek tortoise is generally characterized by low mortality, whereas a severe, acute to sub-
acute disease with high mortality has been observed in Hermann’s tortoises (Testudo her-
manni) [14].
Although numerous serological and molecular tests have been developed to diagnose expo-
sure and infection with TeHV3 [33, 34–38], none of these tests can predict the virulence of the
strain or whether one or several strains are involved within a single outbreak. To better under-
stand the biology of this virus, we decided to sequence the complete genome of the TeHV3
type-strain 1976/96 [34, 36], the best characterized TeHV3 strain to date, to provide a complete
reference genome sequence for TeHV3. Knowledge of this complete sequence in synthesis with
further phylogenetic and experimental data would facilitate a better understanding of the host-
pathogen relationship in chelonians and the development of more refined diagnostic tests con-
tributing to predict the outcome of an outbreak. In addition, in this study we selected the
sequence of the glycoprotein B (gB), gene as a tool to perform a higher resolution phylogenetic
analysis on TeHV3 strains. The choice of the gB gene over other TeHV3 genes was based on its
key features as an ideal phylogenetic marker including conservation among herpesviruses and
sequence variability secondary to its antigenicity [39, 40]. These characteristics are expected to
refine the resolution power of the viral DNApol sequence since the protein encoded by this
gene is expected to be under a negative evolutionary pressure because of strong functional con-
straint. As we will show, the gB sequence allowed us to separate TeHV3 strains into at least two
distinct genogroups. Moreover, we present preliminary data consistent with distinct gen-
ogroup-associated pathology in naturally and experimentally infected tortoises. We provide
the first evidence of homologous recombination in a reptilian herpesvirus with indirect proof
of a single tortoise infected with multiple strains of TeHV3. These new data will be fundamen-
tal for further investigations on host-pathogen interactions in chelonians and for tortoise con-
servation around the world.
TeHV3 genome and host-pathogen interaction
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In this manuscript we also propose to uniform the nomenclature of the TeHVs strains by
presenting in the following order: the abbreviation of the country where the strain originated,
followed by the original number assigned to the strain and the last two digits corresponding to
the year of isolation. According to this procedure, the type strain 1976/96 will be renamed as
(TeHV3)-US1976/98. All the other TeHVs strains investigated in this study will be named
accordingly.
Material and Methods
Genome sequencing
The TeHV3 strain US1976/98 was grown on Terrapene heart cells (TH-1;ATCC-CCL 50 Sub-
line B1; American Type Culture Collection, Rockville, MD, USA), harvested and pelleted as
previously described [36]. Total DNA was extracted using the DNAeasy kit (Qiagen Hom-
brechtikon, Switzerland). A total of 3.5μg of viral DNA was delivered to a biotechnology com-
pany (Fasteris SA, Geneva, Switzerland) for next generation sequencing (NGS). The viral DNA
was processed using the Illumina technology for NGS. Briefly, the DNA was fragmented to
produce short DNA inserts to build a DNA template library with each of the inserts carrying
universal adaptors. Following quality control, the library was sequenced with the Illumina
HiSeq 2000 to obtain 50 base long single-end reads. De novo genome assembly was performed
using the VELVET software (http://www.ebi.ac.uk/~zerbino/velvet/). To optimize the assem-
bly, several values of k-mers were tested. To evaluate the quality of the assemblies, the following
indicators were computed: sum of the contigs (DNA consensus sequences obtained by overlap-
ping shorter DNA sequences) lengths, number of contigs, N50 (the length of the smallest con-
tig in the set that contains the fewest (largest) contigs whose combined length represents at
least 50% of the assembly) [41], number of contigs to reach the N50, average and maximum
lengths of the contigs, and the number of reads from the library that can be mapped on the
contigs. The assembly with the highest N50 and percentage of mapped reads was then chosen.
Bridging of the contigs was performed using viral sequences obtained from two previously
generated sub-genomic DNA libraries (HindIII and EcoRI) [10] [34]. Following the assembly,
multiple PCRs spanning 1–7.5Kb were performed to assess the junctions between contigs and
the overall correctness of the assembly of the whole genome. Sequencing of the PCR products
was carried out when the amplicon obtained was not consistent with the expected size derived
from the sequenced genome. Finally, the single-end Illumina reads were mapped to the
obtained genome sequence using BWA (Burrows-Wheeler aligner (http://bio-bwa.sourceforge.
net)) [42]; the remapping was visualized with IGV (Integrative Genomic Viewer 2.3.34) [43].
For open reading frame (ORF) identification the program “ORF finder” (http://www.ncbi.nlm.
nih.gov/projects/gorf/) was used and each putative ORF was manually assessed using the pro-
gram “BLAST” (http://blast.ncbi.nlm.nih.gov/Blast.cgi). The gene identity was attributed
according to the best hit provided by BLAST. An arbitrary cutoff corresponding to predicted
genes encoding for at least 90 amino acids (aa) was selected when no homology could be found
with any other known herpesviral genes using BLAST. Detection of the tandem repeats was
carried out using the software “Tandem repeat finder” [44], using standard settings.
Genome comparison. The TeHV3 genome was compared with that of Chelonid herpesvi-
rus 5 (ChHV5), the only other available genome of a chelonian herpesvirus [22] using the pro-
gram EasyFig v2.1 [45] with standard settings. Briefly the annotation files of the two genomes
(HQ878327-ChHV5 and KT008627-TeHV3) were converted by the software into the corre-
sponding tBLASTX files [45]. The graphic output of the comparison was then generated. Color
tones from light gray to black were selected for the direct matches spanning from low to high,
respectively, and orange to red for the inverted matches spanning from low to high, respectively.
TeHV3 genome and host-pathogen interaction
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Animals and pathology
A retrospective investigation was carried out on selected formalin-fixed, paraffin embedded
(FFPE) tissues obtained from ten tortoises necropsied from 1999 to 2009 and stored in the
archive of the Centre for Fish and Wildlife Health (FIWI) of the University of Bern, Switzer-
land. All the tortoises selected for the study were captive animals and were either diagnosed as
presumptively infected with TeHV or carrying compatible lesions based on having at least one
of the following criteria: 1) eosinophilic to amphophilic intranuclear inclusions in at least one
of the examined tissues (= presumptively infected); 2) presence of diphtheronecrotic stomatitis
and/or glossitis (= compatible lesion); and 3) pneumonia (= compatible lesion). All these tor-
toises died of natural causes, with the exception of Z02/1970 that was humanely euthanized by
the attending clinician because of very poor prognosis with an overdose of sodium pentobarbi-
tal performed by intra vascular injection. None of these tortoises was included in experimental
studies. Two additional tortoises (PN186/12, PN13/08), selected using the above criteria, were
provided by the University of Milan (Italy) along with a third tortoise (PN191/12) that despite
absence of consistent lesions was also included in the study because it came from the same die
off as PN186/12. A tortoise with a diphtheronecrotic stomatitis (S12/1458) submitted for nec-
ropsy to the Institute of Animal Pathology (ITPA) of the University of Bern was also included
in the study. The three tortoises provided from the University of Milan and the tortoises sub-
mitted to the ITPA also died of natural causes and were not part of any transmission study.
Finally, a tortoise (TG4/1998) experimentally infected with the TeHV3 type-strain US1976/98
with well-characterized associated pathology [34] was also considered for this study. This tor-
toise was part of a transmission study carried out previously. The study was approved by the
Institutional Animal Care and Use Committee (IACUC) of the University of Florida and the
tortoise was humanely euthanized with an overdose of sodium pentobarbital performed by
intracoelomatic injection [34]. All the tissues available from all the tortoises were reviewed by
two of us (FCO and MT). The following data was obtained for each tortoise: 1) time of death;
2) sex; 3) species; 4) age; 5) geographical origin 6) presence of any inflammatory, necrotic or
degenerative lesions in any of the sections observed using light microscopy, and presence and
location of the intranuclear inclusions. No live animals were included in this study. A detailed
list of the tortoises included in this study including the identification numbers of each animal
is provided in Table 1.
Virus isolation
Virus isolation was attempted from fresh tissues obtained from tortoises PN186/12 and
PN191/12 (from the University of Milan, Italy) and from an oral swab from tortoise S12/1458
(from the ITPA of the University of Bern, Switzerland). Tissues and swabs were processed for
viral isolation by inoculation onto TH-1 cells at 28°C as previously described [34]. Cell cultures
were monitored daily for the detection of cytopathic effects (CPE). The type-train 1976/96 was
already available from previous studies [34, 36].
TeHV3 strain detection and partial characterization of the gB gene
Total DNA was extracted either from infected cell cultures (strains 1976/96, CH1458/12 and
IT191/12) or from FFPE tissue blocks containing at least a section of the tongue and/or oral
mucosa or lung from all the remaining tortoises in the study. Three 20 μm sections were
obtained from each of the selected paraffin blocks and placed into an RNAse/DNAse-free 1.5
ml Eppendorf tube. Total DNA was extracted from each set of paraffin slices with the FFPE
DNA extraction kit (Qiagen Hombrechtikon, Switzerland). Total DNA was also extracted
from infected cell cultures as previously described [34] (Origgi et al., 2004) and quantified
TeHV3 genome and host-pathogen interaction
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with a Nanodrop spectrophotometer (Thermo Scientific, Wilmington, DE, USA). The com-
plete gB gene of strains US1976/98, CH1458/12 and IT191/12 was amplified by PCR with a for-
ward (gBTeHV3FW) and a reverse (gBTeHV3RV) primers (Table 2) which were designed on
the basis of the sequence available from the US1976/98 genome (KT008627). The PCR reac-
tion-mix contained 5 μl of 2 μM forward and reverse primers, 1.25 μl of each 10 mM dNTPs
(Promega, Madison, WI, USA), 5 μl of 10x PCR buffer, 1 μl of PFU II Ultra DNA polymerase
(Agilent Technologies, Santa Clara, CA, USA) 250 ng of total DNA template and double dis-
tilled water (Promega, Madison, WI, USA) up to 50 μl. PCR reactions were carried out in a
DNA engine thermal cycler (MJ Research, Waltham, MA, USA) and comprised an initial dena-
turation step at 95°C for 2 minutes, followed by 40 cycles comprising a denaturation step at
95°C for 30 seconds, an annealing step at 50°C for 30 seconds and an elongation step at 68°C
for 1 minute followed by a final elongation step at 68°C for 10 minutes. Given that FFPE tissues
undergo DNA fragmentation, no full amplification would have been possible with a single
PCR reaction. Consequently, either full or partial gB gene amplification from the paraffin
blocks-derived DNA was carried out with a series of sequential and overlapping PCR reactions,
which were set up with each of the subgroup of primer sets listed in Tables 2 and 3, respec-
tively. More specifically, the pairs FWA and RVA, FW1 and RVB, FW2 and RVC, FW3 and
RVD, FW4 and RVE, FW5 and RVF, FW6 and gBTeHV3RV were used to amplify several
DNA fragments covering the full length gB of strain CH6883/03, while the primer pairs FW4
and RVE, FW5 and RVF, FW6 and gBTeHV3RV were used to amplify the 3’ half portion of
the gB gene of all the other paraffin-blocks-derived strains in the study. Each of the PCR reac-
tion mixes contained 0.25 μl of 10 μM forward and reverse primers, 12.5 μl of hot-start master
mix (Qiagen AG, Hombrechtikon, Switzerland), 250 ng of total DNA template and double dis-
tilled water (Promega, Madison, WI, USA) up to 25 μl. The reaction mixes were placed in a
DNA engine thermal cycler (MJ Research, Waltham, MA, USA) and after an initial denatur-
ation at 95°C for 15 minutes (hot start), 45 cycles comprising denaturation at 95°C for 1 min-
ute, annealing at 50°C (FWA and RVA, FW4 and RVE, FW5 and RVF) or 52°C (FW1 and
RVB, FW2 and RVC, FW3 and RVD, FW6 and gBTeHV3RV) for 30 seconds, an elongation at
72°C for 30 seconds, followed. A final step comprising 10 minutes extension at 72°C was
Table 2. PCR and sequencing primers.
Primer name Primer sequence (5’-3’)
FWA TTTGGTTATCATATTAGGAGCG
RVA ACGTCTATTATTTCGTCACGC
FW1 GAGCATAGGTCATAGAACAACTATACG
RVB GTCCTCGTTCATAGTTTCGG
FW2 AGATGTCTCCATTCTACGATAGAACC
RVC CAGATGAGTATCCTTGTACCG
FW3 CCGACCGAAGGCAAAAAAGAAATAGA
RVD AAACGCGACGCTTCATTATGG
FW4 ACAATTAAATAAAATAAATCCC
RVE ATATACGTGCTTACTTCTGGG
FW5 ATAATTTTGTTAGGATGGTTC
RVF TAAAATGATAGTAAATCCTCC
FW6 TTTTTCAGTAACCCGTTCGGAGG
gBTeHV3FW AAAATGATCATGTGGTTATCGTT
gBTeHV3RV AAAATTATTGGGAGGAATCGTCTATCT
doi:10.1371/journal.pone.0134897.t002
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added. A summary of the primer pairs used for the gB gene amplification and cycling condi-
tions is listed in Tables 2 and 3.
Partial amplification of the DNApol gene
The partial sequence of a highly conserved portion of the TeHV3 DNApol gene, accounting
for 5% of the entire DNApol gene was carried out as previously described [33].
Sanger Sequencing
Sequencing of the DNApol (partial sequence) and gB amplicons (partial and full length gB
gene) was performed with an automated sequencer ABI Prism 3100 genetic analyzer (Applied
Biosystems, Foster City, CA, USA) with the BigDye Terminator cycle sequencing kit (Applied
Biosystems, Foster City, CA, USA). The primers used for the sequencing reactions were the
same to those used to obtain the amplicons, respectively (see Tables 2 and 3). Sequencing of
the partial DNApol gene amplicons was performed with the primer set recommended by Van-
devanter et al. [33].
Phylogenetic analyses
Multiple phylogenetic analyses were carried out. The first analysis (1) was based on the partial
aa sequence of the DNApol and gB proteins, respectively, encoded in the genome of the
TeHVs strains included in this study (N = 15). These sequences were compared to homologous
sequences available from other herpesviruses (TeHV1-AB047545.1, TeHV2-AY916792.1,
TeHV4-GQ222415.1, ChHV5-AF239684.2, ChHV6-EU006876.1 and GaHV1- AF168792.1
for the DNApol; and ChHV5-AAU93326, ChHV6-AAM95776 and GaHV1-YP_182356 for
the gB sequences). The second analysis (2) was based on the partial nt sequences of the gB gene
of all the TeHV3 strains included in this study (n = 15), which were compared to the homolo-
gous gene of other herpesviruses (ChHV5-AAU93326, ChHV6-AAM95776 and GaHV1-
YP_182356). The third analysis (3) was carried out using the complete aa sequence of the gB
protein of the reference strain (US1976/98), which was compared to homologous sequences of
Table 3. Glycoprotein B gene PCR amplification conditions.
Glycoprotein B ampliﬁcation conditions
gB ampliﬁcation Primer sets Amplicon size
(nt)
Cycling conditions
Full (from fresh tissues) gBTeHV3FW-
gBTeHV3RV
2,484* 95°C for 1’ + 40 cycles = 95°C for 30”, annealing at 50°C for 30” + 68°C for 1’.
Final elongation step at 68°C for 10’
Full (from formalin-ﬁxed
tissues)
FWA-RVA 524* 95°C for 15’ (hot start)+ 45
FW1-RVB 409* cycles = 95°C-1’ + annealing
FW2-RVC 413* at 50°C (FWA and RVA,
FW3-RVD 409* FW4 and RVE, FW5 and
FW4-RVE 405* RVF) or 52°C (FW1 and
FW5-RVF 389* RVB, FW2 and RVC, FW3
FW6-gBTeHV3RV 387* and RVD, FW6 and
Partial FW4-RVE 405* gBTeHV3RV) for 30”, +
FW5-RVF 389* 72°C for 30”. A ﬁnal
FW6-gBTeHV3RV 387* elongation step for 10’ at 72°C
* Expected amplicon size including primers
doi:10.1371/journal.pone.0134897.t003
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36 other herpesviruses. Sequence alignment was carried out using multiple software packages
(ClustalW, ClustalW2, TCoffee, Mafft L and Muscle) [46–49] for phylogenetic analysis 1,
whereas ClustalW was used for analysis 2 and 3. Maximum likelihood phylogenetic trees were
obtained using MEGA6.0–6 [50] software package with 500 bootstrap replications, Jones Tay-
lor Thorton replication method, uniform rates among sites and very strong branch swap filter.
Recombination analysis
Assessment of recombination events of the gB gene was carried out with the Recombination
Detection Program (RDP4) (Version 4.46) [51] using standard settings and feeding the soft-
ware with two of the predicted parent strains (US1976/98 and CH6883/03) together with the
predicted recombinant strain (CH3429/01). The methods used for the recombination assess-
ment were those included in the software package and included RDP, GENECONV, BootScan,
MaxChi, Chimera, SiScan, PhylPro, LARD and 3Seq, all operating under standard settings.
Results
Sequence analysis of the TeHV3 genome
Next generation sequencing (NGS): A total yield of 1.598 mega bases (Mb) was obtained with
31,959,585 clusters. 95.8% of the bases had a Q-score (measure of base-calling accuracy) larger
than 30. The de novo assembly of the reads led to a total of 24 contigs spanning from 107 to
64,501 nt long and accounting for 140,195 nt (N50 of 23,603 nt). The average base coverage
(depth) was 8,984. Bridging of the contigs was carried out by PCR and with the aid of the
sequencing information derived from theHindIII and EcoRI subgenomic libraries as previously
mentioned. The final sequence of the genome comprised 150,080 nt (Fig 1). The TeHV3 genome
is composed of a unique long (UL) and a unique short (US) region, with the US flanked by
inverted repeats consistent with a type D arrangement similar to that ofHuman herpesvirus 3
(HHV3-VZV) and the recently described genome of ChHV5 [22]. The GC content was 45.8%.
Analysis of the sequence of the unique long (UL) region. The length of the available UL
region was determined to be 112,838 nt (position 37,243 to 150.080 of the genome). The puta-
tive 5’ and 3’ ends of the UL region were identified as those regions immediately contiguous to
the inverted and terminal repeats, respectively. The putative 5’ end of the UL region was
obtained by NGS complemented with the sub-genomic library approach, whereas the sequence
of the putative 3’ end was obtained by sequencing a PCR amplicon bridging the 5’ end region
of the terminal repeat and the 3’ end of the UL region. This approach was attempted given that
herpesvirus genomes are known to adopt a closed circle configuration within a few hours after
the start of replication [52]. By harvesting the total DNA of early-infected TH-1 cells, we could
successfully amplify the bridging regions between the terminal repeat and the 3’ end of the UL
region. The actual putative 3’ end of the UL region was considered to be the last nucleotide
prior to the beginning of the sequence corresponding to the reverse and complement of the 3’
end of the internal inverted repeat. Multiple PCRs confirmed the assembly obtained.
The predicted UL region comprises at least 79 ORFs; 37FW, 42RV, with 35 partially over-
lapping. Sixty-two of them showed variable degrees of similarity with known herpesvirus
genes, ranging from 38 to 79% for the UL47 (Psittacid herpesvirus 1) and UL 45 (Ateline herpes-
virus 3) homologues, respectively. The remaining ORFs could not be associated unambiguously
to a known herpesvirus gene (Table 4 and Figs 1 and 2).
The UL ORFs are largely co-linear to the homologous genes of Human herpesvirus 1
(HSV1), in particular from UL1 to UL43, while the segment spanning from UL53 to UL44 has
an inverted orientation compared to HSV1. Two genes share homology with HSV1 UL55
(UL55a and UL55b), with 74% nt identities between each other, suggesting gene duplication.
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TeHV3 encodes for the thymidylate synthetase (UL45), whose homologue is found only in
Varicella zoster virus (VZV) of all the Alphaherpesvirinae, whereas is common in Gammaher-
pesvirinae. The longest gene identified in the UL region was the homologous of HSV1 UL36,
encoding for the large tegument protein. This gene is 7,725 nt long and encodes for a protein
2,574 aa long. In contrast, the shortest gene identified within the UL region is the homologous
gene of HSV1 UL11. The gene is 240 nt long and encodes for a 79 aa long protein. Finally,
upstream of the homologous gene of HSV1 UL1 is a 333nt ORF (ORF24b) encoding for a pre-
dicted 110 aa long protein that shares 51% similarity with a motif of a predicted protein with
unknown functions encoded by Bovine herpesvirus 6 (Table 4). Interestingly, almost entirely
overlapping with ORF24b is ORF24a, which is another predicted ORF whose encoded pre-
dicted protein shares very limited similarities with a protein encoded by the retroperitoneal
fibromatosis-associated herpesvirus (Genbank AGY30683) (Table 4).
Interestingly, the UL region of ChHV5, the closest related herpesviral genome to TeHV3,
lacked several genes compared to TeHV3. More specifically, the HSV1’s UL13, UL40, UL44
through 51 and UL54 through UL56 homologous genes could not be detected in the ChHV5
genome [22]. In contrast, homologues of all these genes except for UL56 were identified in the
Fig 1. TeHV3 genomemap. The TeHV3 genome is composed of a unique long region (UL) (blue bar) and a unique short region (US) (green bar) flanked by
two inverted repeats (red bars). The progressive numbers and the homologous herpesvirus genes of the identified sense (orange) and antisense (green)
open reading frames (ORFs) are shown in the map (SnapGene Viewer-V2.7; www.snapgene.com).
doi:10.1371/journal.pone.0134897.g001
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Table 4. TeHV3 Open reading frames features.
ORF HV Homologue Protein Function/ description Similarity* Position Length (nt) Frame
1 HHV6 IE2 Transactivator 40%77/188 1,097–3,916 2,820 +
2 ChHV5 ICP4 Transactivator 58%41/70 4,897–7,737 2,841 -
3 N/A UNKN N/A N/A 8,948–9,580 633 +
4 N/A UNKN N/A N/A 9,555–10,280 726 +
5 N/A UNKN N/A N/A 10,704–11,444 741 -
6 N/A UNKN N/A N/A 11,864–13,348 1,485 +
7 N/A UNKN N/A N/A 13,041–14,798 1,398 +
8 ChHV5 US3a Serine/Threonine Kinase 54% 181/333 14,902–15,993 1,092 +
9 ChHV5 US3b Putative cyclin-dependent kinase 2 50% 153/305 16,026–16,964 939 +
10 ChHV5 gD Cell receptor ligand 44%78/175 17,055–17,858 804 +
11 HPV2 gE-like Unknown 41%58/141 17,874–18,542 669 +
12 N/A UNKN N/A N/A 18,557–19,957 1,401 -
13 N/A UNKN N/A N/A 20,069–20,512 444 +
14 ChHV5 gE Host interaction and immunoevasion 41%159/387 20,634–22,031 1,398 +
15 N/A UNKN N/A N/A 22,141–22,416 276 -
16 ChHV5 US10 Zinc-ion binding/ Tegument/capsid protein 54%106/194 22,683–23,429 747 -
17 N/A UNKN N/A N/A 23,448–25,085 1,638 +
18 N/A UNKN N/A N/A 25,127–25,489 363 -
19 N/A UNKN N/A N/A 25,572–26,120 549 -
20 N/A UNKN N/A N/A 26,268–26,969 702 -
21 N/A UNKN N/A N/A 27,050–28,438 1,388 -
22 ChHV5 ICP4 Transactivator 58%41/70 29,506–32,346 2,841 +
23 HHV6 IE2 Transactivator 40% 77/188 33,327–36,146 2,820 -
24a RFHVMn Rep Protein Unknown 38%34/88 38,525–38860 336 +
24b BoHV6 Bov2.bl Unknown 51%44/85 38,574–38,906 333 -
25 PsHV1 gL Viral entry 58%33/56 39,402–39,856 384 +
26 ChHV5 UL2 UDG glycosilase 61%156/252 39,792–40,604 813 +
27 ChHV5 UL3 Phosphoprotein 72%154/211 40,685–41,266 582 +
28 ChHV5 UL4 Nuclear protein 50%86/172 41,682–42,365 684 -
29 ChHV5 UL5 DNA helicase/primase cpx 69%598/858 42,416–44,917, 2,556 -
30 ChHV5 UL6 Capsid protein 60%398/654 44,955–46,964 2,010 +
31 ChHV5 UL7 Virion egress protein 53%132/248 46,807–47,622 816 +
32 ChHV5 UL8 DNA helicase/primase cpx 44%336/749 47,627–49,777 2,151 -
33 AnHV1 UL9 Replication origin-binding protein 57%463/810 49,779–52,133 2,355 -
34 ChHV5 gM Virion assembly and egress 66%279/418 52,145–53,383 1,239 +
35 HSV1 UL11 Tegument protein 62%27/43 53,433–53,672 240 -
36 ChHV5 UL12 Alkaline exonuclease 55%271/484 53,606–55,207 1,602 -
37 HSV1 UL13 Serine/threonine kinase 42%184/428 55,208–56,521 1,314 -
38 ChHV5 UL14 Tegument protein 58%58/100 56,443–56,976 534 -
39 ChHV5 UL15A Putative DNA packing protein 64%214/330 56,975–58,090 1,116 +
40 ChHV5 UL16 Capsid binding protein 53%179/332 57,938–58,945 1,008 -
41 ChHV5 UL17 Virion Packaging protein 46%315/676 58,924–60,882 1,959 -
42a ChHV5 UL15B Terminase large subunit 74%267/359 60,986–62,050 1,065 +
42b ChHV5 HP18 Hypothetical protein 43%34/79 62,069–62,523 453 +
42c HHV4 BRRF4 BRRF4 protein 40%41/101 63,118–63,579 462 +
43 ChHV5 UL18/VP23 Capsid protein 65%211/321 63,784–64,746 963 -
44 ChHV5 UL19 Major capsid protein 72%993/1,373 64,821–68,930 4,110 -
(Continued)
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Table 4. (Continued)
ORF HV Homologue Protein Function/ description Similarity* Position Length (nt) Frame
45 ChHV5 UL20 Multifunctional essential for fusion 75%139/184 69,023–69,613 591 -
46 ChHV5 UL21 Tegument protein 45%220/480 69,716–71,068 1,353 +
47 ChHV6 UL22/gH Fusion/cell entry 74%332/445 71,088–73,289 2,202 -
48 ChHV5 UL23/TK De novo DNA synthesis 48%168/345 73,322–74,389 1,068 -
49 BoHV1 UL24 Nuclear protein 52%94/178 74,371–75,345 975 +
50 ChHV5 UL25 Virion packaging 55%323/578 74,960–756,687 1,728 +
51 ChHV6 UL26 Protease 60%352/579 76,726–78,198 1,473 +
52 ChHV6 UL27/gB Cell entry/Fusion 73%637/864 78,251–80,734 2,484 -
53 ChHV5 UL28/ICP18.5 DNA processing and packaging 64%475/742 80,731–83,022 2,292 -
54 ChHV5 UL29/ICP8 Major DNA binding protein 63%735/1,156 82,976–86,527 3,552 -
55 ChHV5 UL30 DNA polymerase 70%809/1150 86,651–90,049 3,399 +
56 ChHV5 UL31 Nuclear matrix protein 67%185/275 89,991–90,878 888 -
57 ChHV5 UL32 DNA cleavage/packaging 63%296/466 90,884–92,497 1,614 -
58 ChHV5 UL33 DNA processing and packaging 66%72/108 92,478–92,825 348 +
59 ChHV5 UL34 Inner nuclear membrane protein 53%143/269 92,827–93,555 729 +
60 PsHV1 UL35 Small capsid protein 52%24/46 93,565–93,909 345 +
61 ChHV5 UL36 Large tegument protein 44%942/2101 93,906–101,630 7,725 -
62 ChHV5 UL37 Capsid assembly 43%461/1051 101,696–104,866 3,171 -
63 ChHV5 UL38 Capsid protein 56%256/455 104,868–106,211 1,344 +
64 ChHV5 UL39 Ribonucleotide reductase L.s. 62%490/787 106,315–108,705 2,391 +
65 FeHV1 UL40 Ribonucleotide reductase S. s. 73%220/301 108,728–109,642 915 +
66 ChHV5 UL41 Virion host shutoff protein 62%212/338 109,637–110,596 960 -
67 ChHV5 UL42 DNA polymerase processivity factor 48%147/304 110,732–111,838 1,107 +
68 ChHV5 UL43 Membrane protein 45%178/393 111,932–113,122 1,191 +
69 EqHV3 UL54/ICP27 Transactivator 50%109/214 113,152–114,438 1,287 -
70 N/A UNKN N/A N/A 114,557–115,162 606 +
71 ChHV5 UL53/gK Intracellular fusion 64%227/353 115,194–116,234 1,041 -
72 ChHV5 UL52 DNA primase 55%490/880 116,231–118,951 2,721 -
73 PsHV1 UL51 Tegument protein 47%82/174 118,950–119,600 651 +
74 MeHV1 UL50 Deoxyuridine triphosphatase 50%82/163 119,642–120,985 1,344 -
75 BoHV6 ORF53/UL49.5 Tegument/envelope protein 48%48/100 120,984–121,286 303 +
76 AnHV1 UL49.2 Tegument protein 60%59/98 121,352–121,990 639 +
77 SuHV1 UL48 Tegument protein 43%163/378 122,083–123,369 1,287 +
78 PsHV1 UL47 Tegument protein 38%95/247 123,467–124,888 1,422 +
79 AnHV1 UL46 Tegument protein 42%95/223 124,881–126,092 1,212 +
80 HHV3 UL45 Thymidylate synthetase 79%98/124 128,556–128,930 375 +
81 CeHV9 UL44/gC Ligand/immunoevasion 45%104/228 128,974–130,026 1,053 -
82 N/A UNKN N/A N/A 130,062–130,850 789 -
83 N/A UNKN N/A N/A 130,954–131,490 537 -
84 HHV4 EBNA-3C Nuclear protein 52%39/75 131,690–133,450 1,761 -
85 N/A UNKN N/A N/A 133,338–134,915 1,578 +
86 N/A UNKN N/A N/A 134,954–136,252 1,299 +
87 BoHV2 UL55a Unknown 39%43/110 136,355–137,020 666 -
88 N/A UNKN N/A N/A 137,152–137,841 690 +
89 ChHV5 UL55b Unknown 44%28/63 138,014–138,670 657 -
90 N/A UNKN N/A N/A 138,799–139,494 696 +
91 N/A UNKN N/A N/A 139,517–140,005 489 -
(Continued)
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TeHV3 genome. UL13 encodes for a serine-threonine protein kinase, whereas UL40 encodes
for the small subunit of the ribonucleotide reductase. UL44 encodes for the glycoprotein C, a
surface membrane protein which mediates immune evasion in vivo [53], while UL45 encoded
for thymidylate synthetase. UL46, UL47, UL48 UL49.2, UL49.5 and UL51 encode for tegument
proteins. UL50 encodes for a metabolic enzyme (dUTP diphosphatase). UL54 encodes for a
transcriptional regulator (similar to ICP27), while UL55 encodes a protein with unknown func-
tions. Ackermann and colleagues [22] reported that all the homologues genes from HSV-1 that
Table 4. (Continued)
ORF HV Homologue Protein Function/ description Similarity* Position Length (nt) Frame
92 N/A UNKN N/A N/A 140,190–142,040 1,851 -
93 N/A UNKN N/A N/A 142,037–143,752 1,716 -
94 N/A UNKN N/A N/A 144,464–144,760 297 -
95 N/A UNKN N/A N/A 144,780–145,166 387 +
96 N/A UNKN N/A N/A 145,269–146,831 1,563 -
97 N/A UNKN N/A N/A 146,976,-148,493 1,518 -
98 N/A UNKN N/A N/A 148,510–148,968 459 +
99 N/A UNKN N/A N/A 149,077149,700 624 -
*The number at the denominator indicates the total length of the portion of the herpesviral homologous protein being compared by BLAST with TeHV3.
The number at the numerator indicates the actual number of the amino acid residues of TeHV3 showing similarities with the compared portion of the
homologous protein. The percentage summarizes the overall similarity between TeHV3 and the speciﬁc herpesvirus homologous protein for the speciﬁc
motif considered.
doi:10.1371/journal.pone.0134897.t004
Fig 2. TeHV3 and ChHV5 genome comparison. The graphical comparison between TeHV3 and ChHV5 genomes obtained with the EasyFig1 software is
shown in the figure. The genomes of TeHV3 and ChHV5 are depicted in red, with a black backbone. Similar regions are connected with gray (low) to black
(high) (direct sequences) and orange (low) to red (high) (inverted sequences) bars. Green, blue and red bars highlighting the US and UL regions and of the
inverted repeats (terminal and internal) of each genome, respectively are also shown. Letters A, B, C, D, E and F correspond to regions of the genomes that
show no similarities within the conserved UL block.
doi:10.1371/journal.pone.0134897.g002
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are missing in ChHV5 in comparison with TeHV3 are known to be non-essential for herpesvi-
rus replication in vitro. The biological meaning of these different sets of genes in TeHV3 is cur-
rently unknown. Table 4 provides a summary of all the comparison data.
Analysis of the sequence of the unique short (US) region. The US region was identified
as the portion of genome between the terminal and inverted repeats. It is predicted to be 20,374
nt long (position 8,435 to 28,808 of the genome) and comprises at least 19 ORFs (11 FW, eight
RV, two overlapping). Only five of the detected ORFs shared a relatively significant similarity
with other known herpesviral genes (ORF8 and 9 with US3; ORF10 with gD; ORF14 with gE;
ORF16 with US10) (Table 4). There are two genes that share high similarity with HSV1 US3,
US3a (ORF8) and US3b (ORF9) (see below). ORF8 and 9 do not share any significant similar-
ity between each other (only 10 positive aa between the two sequences), suggesting that an ori-
gin by gene duplication is unlikely. Fifty four per cent sequence similarity was observed
between the TeHV3 ORF8 encoded protein and ChHV5 US3 protein homologue, whereas 50%
sequence similarity was observed between the TeHV3 ORF9 encoded protein and the putative
cyclin-dependent kinase 2 of ChHV5. The predicted protein encoded by the ORF 10 of TeHV3
shared 48% sequence similarity with a 175 aa long motif of ChHV5 glycoprotein D (gD), a
molecule that is known to serve as the major receptor-binding protein in a number of Alpha-
herpesvirinae [22] (Table 4).
The longest predicted gene detected in the US region encoded for a protein of 545 aa, identi-
fied as TeHV3 ORF17, that did not share any similarity with any gene of known herpesviruses.
The shortest ORF detected in the US region was instead identified as TeHV3 ORF15 and
encoded for a 91 aa long protein and did not show any similarity with other known herpesvirus
genes. The highest similarity between the identified proteins encoded by the TeHV3 US region
and those of other herpesviruses was observed for the homologue of HSV1 US3 (see above)
and of US10, both with 54% similarity with the correspondent protein encoded by ChHV5
(Table 4). Otherwise, the lowest similarity was observed for the glycoprotein E (gE) (ORF14)
and of a gE-like protein (ORF11), with 41% similarity for the homologous proteins encoded by
ChHV5 and Cercopithecine herpesvirus 6, respectively. No similarities could be found between
the other TeHV3 US encoded predicted proteins and those of other known herpesviruses.
Overall, findings were similar to those described for the US region of ChHV5, except for the
number of ORFs identified, which in ChHV5 were 11 versus the 19 identified in TeHV3.
Table 4 provides a summary of all the comparison data.
Analysis of the sequence of the inverted repeats (Internal and terminal repeats). The
regions identified as putative inverted repeats are both 8,434 long (position 1 to 8,434 and posi-
tion 28,809 to 37,242 of the genome). The beginnings and the ends of the inverted repeats were
identified as those regions immediately contiguous to unique sequences of either the UL or US
regions. The inverted repeats encode for at least two predicted proteins with motifs sharing 58
and 40% similarity with two known transactivators, ICP4 (ORF2 and 22) and IE-2 (ORF1 and
23),(Table 4).
No detectable latency associated transcript (LAT) encoding gene was detected, in contrast
with ChHV5. Strikingly, a major difference in the number of the predicted ORFs was observed
between the inverted repeat regions of TeHV3 and that of ChHV5, where 12 ORFs were identi-
fied. However, while in ChHV5, the cutoff selected for the detection of the ORFs was 40 aa, we
considered only the ORFs predicted to encode at least 90 aa as mentioned above (Table 4).
Finally, five additional putative ORFs encoding more than 90 aa were actually identified in the
TeHV3 inverted repeats, however, they were almost entirely clustered within the ICP4 homolo-
gous coding sequence and all of them showed very low similarities only with very short motifs
of known herpesvirus genes and consequently were not considered in the final list of TeHV3
putative genes.
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Tandem repeats. A total of 17 tandem-repeat regions were identified and the length of the
repeat motifs ranged from 13 to 73 nt (Table 5). Four of them mapped within the UL region,
eight in the inverted repeats, three in the US region, one bridging between UL region and the
inverted repeat and one bridging between US and inverted repeat. In four of the repeated
motifs up to 4 mismatches were observed. Two indels were also observed (Table 5).
Ambiguous sequencing results. In the region comprised between the homologous genes
to UL44 and UL55 we identified a tandem repeat region. The PCR bridging this repeated
sequence yielded a product that appeared to be approximately 50 nt longer than the original
predicted sequence. Several attempts to sequence that region failed. Similarly, the region across
UL15b and UL18, which also contains repeated sequences, might be approximately 200 nt
shorter than predicted by the original sequence.
The putative 3’ end of the UL region comprises a 5.4 Kb contig that was originally assembled
in the opposite orientation of the one then determined to be the correct one. The ambiguity
was determined by the conflicting results of a short bridging PCR over the sequence gap, which
could not be confirmed with a long bridging PCR. The orientation of the contig presented in
the final sequence here was selected on the basis of PCR and sequencing results. Similarly,
between the IE-2 and ICP4 homologues we identified a GC rich region 1,015 nt long with
repeated motifs (tandem repeats). Interestingly, the PCR product spanning between the two
genes over the GC rich region showed multiple bands ranging from approximately 900 to 700
nt, but all smaller than the expected product. However, when running a PCR positioning the
primers distally from the GC rich region, an amplicon of the expected size was obtained. The
pattern of the short bridging PCR results was very similar to that described by Hommelsheim
and colleagues [54] when sequencing repetitive DNA sequences.
In the context of a different research project, while screening subgenomic clones of TeHV3
strain US1976/98 obtained by partial digestion of the genomic DNA with Sau3AI we detected
a repeated motif comprising alternating long series of single A, T, C or G (up to 22 nt long)
that we could not find in the assembled genome. This repeated motif was contiguous with a
sequence that was only partially matching that bordering a similar, but different repeated
motifs at the beginning of the putative UL region. Blasting the novel identified nt motif (with
the option “somewhat similar sequences” of BLAST) no match with any of the known herpes-
viruses was observed. Contrastingly, when the search was not restricted to herpesviruses only,
identities up to 84% of portions of the sequence (up to 33%) with eukaryotic organisms (Ory-
zias latipes-HG313981.1) were observed.
Finally, the original sequence of the TeHV3 genome was determined to be 170 nt longer
than the one presented in this article. This additional sequence was located at the 5’ end of the
terminal repeat and it was one of the two motifs of a tandem repeat originally identified in that
region. When assessing the assembled genome by the software IGV, a total of 12 ambiguous nt
were observed across the entire genome. Of these, six clustered in the first 222 nt of the genome
and two were in the last 20 nt of the genome. In particular in association with four of the nt
ambiguities at the 5’ end of the genome (in correspondence of the 5’ end of the terminal
repeat), we also observed an abrupt drop of the coverage. Interestingly this drop in coverage
corresponds to the joining of the two tandem repeats described above (region between original
nt 166 to 172). Multiple attempts of sequencing these regions were carried out, but the presence
of repeated motifs did not allow us to conclusively resolve these ambiguities. Given the cluster-
ing of several sequence and assembly ambiguities in the region across these two tandem repeats
and that once the two tandem repeats were collapsed into just one, the assembly of that region
appeared to be more robust, we considered that this 170 nt fragment might have represented a
sequencing artifact and then it was removed. Following the editing of the sequence according
to what described above, the inverted and tandem repeats, which originally differed in size for
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exactly 170 nt in length, were then both measuring exactly 8,434 nt, further supporting the
editing described above. A possible insertion of a nt was instead detected at position 127,377,
whereas a possible deletion of a nt was observed at position 131,553 of the genome. A drop of
coverage of 30% between contiguous nt was seen at positions 37,191 and 37,242 but the assem-
bly in that region appears solid and no further assessment was considered necessary.
Genome Comparison. The graphic outcome of the software EasyFig1 (Fig 2), highlighted
a prominent conservation of the arrangement of the genes clustering into the central portion of
the UL region of the genome, although showing overall low similarity as suggested by the
Table 5. Tandem repeats features.
Tandem repeat sequence Motif
Length
(nt)
Position Location
CAGACTCCGTCCGTTAGATTTTGTCAAATTCTGGTCGAGTCGAAC 41 241–359 Inv. repeat
ACGTAACCCTAGCTGCTCTAAGGGACA 27 627–720 Inv. repeat
TGTCGGCCACCCTGACTCTACCCCGCTCCGGCCTGCCCCC 40 4015–
4839
Inv. repeat
ATGCATATCATTAAATATGGAGGAGGTTATGGAATGAGGGAAGTCGGCTCCGATTGGTAGTTGGG 73 7949–
8347
Inv. repeat
GGTGGATATGGGTGGATGTATGTTTATGCATATCATTAAAAAT*1 43 8385–
8563
Bridging 5’end
US and inv.
repeat
AAAAGCAAAACACTTGTATAAATTATCCAAT*2 31 16943–
17010
US3 region
GGTTGGGGAGAACGGTCATAATTAGAGGGACCG 33 27528–
27703
ORF 21
TATCCGAGTTACTACCCCCCTGTACCTGCTGGAAAT*3 36 27994–
28312
3’end US
TTCCATAACCTCCTCCATATTTAATGATATGCATCTACCTGCCCCAACTACCAATCGGAGCCGACTTCCCTCA 73 28896–
29294
Inv. repeats
CGGGGTAGAGTCAGGGTGGCCGACAGGGGGCAGGCCGGAG 40 32404–
33228
Inv. repeats
GCTAGGGTTACGTTGTCCCTTAGAGCA 27 36523–
36616
Inv. repeats
ATTTGACAAAATCTAACGGACGGAGTCTGGTTCGACTCGACCAGA 45 36884–
37002
Inv. repeats
CCCTGGATCGGGCCC 15 38589–
38844
ORF 24
ATATATAAATATA 13 62779–
62971
UL15b/UL18
region
GACAACTTGAGGAGGAGGTGGTGGGTG 27 100095–
100169
UL36
GGATCCTTAAACTAGATCCCTTTACATGTAGTATGTTACTATAAAAC 47 127865–
128049
UL45/46 region
GGTGGGGTGATCGGAGGGGTAACCTCTTCT*4 30 131704–
131989
UL44 region
*Presence of mismatches or indels or both in the repeated motifs
1One mismatch
2Four mismatches and one indel
3One mismatch
4One indel
Inv. repeats = Inverted repeats
doi:10.1371/journal.pone.0134897.t005
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predominant light gray of the connecting lines. However, within this highly conserved portion
of the genome, few regions showed absence of virtually any similarity. More specifically, the
regions corresponding to the homologue of UL4 (A), UL12-13 (B), UL16 (C), in that between
the UL15b and UL18 homologues (D) and in that corresponding to the UL22 (E) and UL36 (F)
homologues, none or very limited numbers of connecting lines were observed. The extremities
of the genomes showed a relative low or absence of similarities, with the most relevant clustering
within the US regions of the genomes where low similarity-labeling color (orange) highlighted
corresponding inverted matches (ORF 8-US3a, 9-US3b, 14-gE and 16-US10). No matches
could be observed in the terminal portion of the putative UL regions of the two genomes.
Animals
A total of 15 tortoises were included in this study. Ten of them were diagnosed as presumptively
infected by herpesvirus and five as carrying consistent lesions (or history = IT191/12) based on
the criteria described above. The only exception was tortoise TG4/1998, which although did not
show any intranuclear inclusions in the examined tissues was also considered conclusively
infected by TeHV given that it was part of a previous challenge study carried out with the
TeHV3 strain US1976/98. Ten out of 15 were T. hermanni, one T. horsfieldii, two T. graeca, one
Testudo sp, one Stigmochelys (formerly Geochelone) pardalis. The tortoises died either during
the spring (April-June: n = 8) or the fall (October-December: n = 4) including also Z02/1970
that was euthanized because of very poor prognosis. One animal was part of a terminal trans-
mission study and was euthanized in August. No information was available for two individuals.
Seven were male and six female. No sex information was available for two tortoises. Most of the
tortoises were from Switzerland (n = 11), fewer from Italy (n = 3) and one from the US, account-
ing for three countries and two continents. The selected cases spanned between 1998 and 2012.
A complete summary concerning the tortoises’ information is provided in Table 1.
Virus isolation
Cell cultures inoculated with tissue extracts from tortoise PN191/12 and swab washes from tor-
toise S12/1458 showed CPE consistent with cell rounding, detachment and cell lysis after 7 to
21 days and up to two blind passages performed. The presence of the virus in the supernatants
of the cell cultures showing CPE was confirmed by PCR using the protocol described by Van-
devanter and colleagues [33]. No virus could be isolated from the cell culture infected with the
tissue extracts from tortoise PN186/12.
Characterization of the TeHVs strains sequences
DNA polymerase (DNApol). Partial amplification of the DNApol gene from all the tor-
toises included in the study (N = 15) was carried out with consensus primers according to an
established protocol [33]. The PCR products were consistent with the expected size (181nt)
and the DNA sequences were translated into the predicted 60 aa long sequence (58 aa readable
for strain CH5132/08). Fourteen out of the fifteen sequences shared 100% identity with the
homologous sequence of other TeHV3 strains (DQ343881; TeHV3 1976/96 = US1976/98).
The remaining strain (IT13/08) showed 100% identity with the homologous sequence of
TeHV1 strains (AB047545.1). The aligned sequences along with those of TeHVs reference
strains are shown in Fig 3.
DNApol aa sequence generated for the novel detected TeHV3 strains could not be deposited
in the NCBI/Genbank database because their length was shorter than the minimum accepted.
Glycoprotein B (gB). Within the portion of the genome identified as the UL region a
2,484 nt long ORF was determined to be the homologue of the HSV1 gB gene
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(UL27 = ORF52). The nucleotide sequence encoded for a protein 827 aa long. The protein was
25 aa shorter than the homologue of ChHV5 (852aa; Genbank AAU93326) and 38 aa shorter
than that of ChHV6 viruses (865aa; Genbank AAM95776), the only reptilian herpesviruses
with a complete available gB sequence.
Either complete or partial amplification of the gB gene was successfully obtained for all tor-
toises in the study (N = 15). In particular, the full amplification of the gB gene was obtained for
strains US1976/98, IT191/12 and CH1458/12, and CH6883/03 (Table 1). The sequences
obtained showed the highest variability in the 3’half of the gene. The 3’ half partial sequence of
the gB gene was then selected for phylogenetic analysis. The amplified portion of the gB gene
was 1084 nt long (1069–1084 nt readable according to the amplicons, including the primers)
and was obtained from all the remaining tortoises in the study (Table 1). The alignment of the
complete and partial sequences of the gB genes of the different TeHVs strains revealed the exis-
tence of a total of 66 single nt polymorphisms (SNP) between two groups (genogroups) of strains
(n = 11 and n = 3) named A and B, respectively. Two SNPs were located within the first 102 nt
of the gB sequence, while the remaining 64 clustered in the 3’half of the gene. Furthermore, the
strain CH3429/01 showed intermediate features between genogroup A and B and was identified
as an additional putative group C. Of the 66 SNPs 33 were uniquely differentiating genogroup A
from B (Fig 4). Five of the SNPs were missense, resulting in aa changes (Fig 5). All the missense
SNPs clustered in the 3’ half of the gene. Within a 250 nt-long region of the highly variable por-
tion of the gB gene were clustered most of the SNPs (22 SNPs; 1,521–1,779 nt) differentiating
genogroup A and B; similarly for the additional putative recombinant strain (genogroup C) (Fig
6). This region of the gB gene was then selected as target region for TeHV3 genotyping.
The TeHV strain with intermediate SNPs between genogroup A and B (putative genogroup C)
revealed a sharp regional demarcation of the SNPs arrangement. Briefly, the SNPs overlapping
with those of genogroup A were located in the 3’ end of the hypervariable region of the gB gene,
whereas the SNPs overlapping with those of the genogroup B were located in the 5’ end of the
Fig 3. Alignment and comparison of the partial amino acid sequence of the DNA polymerase protein of the TeHVs strains. The alignment of the
partial amino acid sequences of the DNA polymerase protein shows unique differences between the 4 recognized TeHVs genotypes. All but one of the
detected TeHVs strains had sequences identical to TeHV3, whereas one strain belonged to genotype 1. (The Genbank accession numbers for TeHVs
reference strains were: TeHV1-AB047545.1, TeHV2-AY916792.1, TeHV3 (1976/96 = US1976/98)-DQ343881, TeHV4-GQ222415.1. The partial DNA
polymerase amino acid sequences of the TeHVs strains detected in this study could not be deposited in Genbank because their length was below the
minimum required to be accepted)
doi:10.1371/journal.pone.0134897.g003
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Fig 4. Hypervariable region of the gB gene of TeHV3. The unique nucleotide changes unambiguously differentiating the genogroup A, B and C are shown
in the figure (* = not available nucleotide for the putative group C TeHV strain).
doi:10.1371/journal.pone.0134897.g004
Fig 5. Hypervariable region of the TeHV3 gB protein. Three unambiguous amino acid changes differentiate the A and B genogroups within TeHV3
(colored blocks). The putative genogroup C shows an intermediate sequence between genogroup A and B.
doi:10.1371/journal.pone.0134897.g005
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hypervariable region suggesting the occurrence of homologous recombination (Fig 7). The recom-
bination event was confirmed by the software GENECONV, BootSCAN, MaxChi, Chimaera and
3Seq of the RDP4 package [51]. In particular, the MaxChi software identified the TeHV3 gen-
ogroup A as the most likely major parent and genogroup B as the most likely minor parent.
TeHV DNApol- and gB-based phylogenetic analyses (1, 2 and 3)
The phylogenetic analysis carried out on the partial aa sequences of the DNA pol (Type 1 anal-
ysis) revealed the presence of 14 strains clustering within TeHV3 and one within TeHV1 geno-
types, respectively (Fig 8). In contrast, the phylogenetic analysis based on the partial aa
sequence of the gB protein (Type 1 analysis) revealed the existence of two distinct TeHV3 gen-
ogroups supported by significant bootstrap values (Fig 9). Additionally, the strain CH3429/01
clustered alone in an intermediate position between the two main TeHV3 genogroups parallel-
ing the findings of the gB sequencing described above. The partial gB aa sequence of the single
TeHV1 strain, IT13/08, clustered together with the TeHV3 genogroup A strains (Fig 9). Over-
lapping results were obtained independently from the alignment software used.
The separation between the genogroups A and B was even more robust when the phyloge-
netic analysis was carried out using the 250 nt of the hypervariable region of the gene described
above (Type 2 analysis) (Fig 10).
Finally, when the full gB aa sequence was compared with the homologous sequence of other
well-characterized herpesviruses, TeHV3 clustered unambiguously among the
Fig 6. Selection of hypervariable nucleotide changes for phylogenetic analysis. In a hypervariable region of the glycoprotein B gene spanning across
approximately 250 nt, are clustered 22 of the 33 unambiguous nucleotide changes differentiating the A and B genogroups within TeHV3. This region was
selected for a high-resolution phylogenetic analysis of TeHV3 strains. The light blue block highlights the selected region of the gene. (* = not available
nucleotide for the putative group C TeHV strain).
doi:10.1371/journal.pone.0134897.g006
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Alphaherpesvirinae in close association with ChHV5, the only recognized herpesviral species of
the genus Scutavirus (Type 3 analysis) (Fig 11).
TeHV3 genogroups A and B appear to be associated with distinct
lesional patterns
Pathological examination was performed on all the 15 tortoises in the study. A summary of the
pathological findings is available in Table 1. Briefly, of all the tortoises infected with TeHV3
genogroup A strains (n = 10), four had inclusions limited to one tissue and no inclusions were
detected in any tissue from the remaining tortoises infected with this TeHV3 genogroup. Dif-
ferently, all the tortoises infected with TeHV3 genogroup B (n = 3) showed inclusions in at
least one tissue and two tortoises had inclusions in more than one tissue. Pneumonia was
observed both in tortoises infected with TeHV3 genogroups A and B, but it was overrepre-
sented in the tortoises infected with TeHV3 genogroup B (two out of three). In contrast, in tor-
toises infected with TeHV3 genogroup A, pneumonia was seen in a minority of individuals
(two out of eight with available lung tissue). Furthermore, inclusions were seen in the lung of
both TeHV3-genogroup-B-infected tortoises with pneumonia, while no inclusions were seen
in the affected lungs of tortoises infected with TeHV3 genogroup A. Of the tortoises infected
with TeHV3 genogroup A for which brain tissue was available (n = 6) only one showed tissue
changes consistent with meningitis. In contrast, meningitis was seen in two out of the three tor-
toises infected with TeHV3 genogroup B. Vasculitis and/or perivasculitis were observed in two
Fig 7. Glycoprotein B homologous recombination. The putative C genogroup shows full identity with either genogroup A or B partial gB nt sequence
according to the portion of the hypervariable region considered. This arrangement is consistent with the outcome of homologous recombination. The
highlighted sequence blocks show the homologous regions between the gB sequences of B and C and A and B genogroups, respectively (* = not available
nucleotide for the putative group C TeHV strain).
doi:10.1371/journal.pone.0134897.g007
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out of three individuals infected with the TeHV3 genogroup B. The tortoise infected with the
bona fide recombinant TeHV3 strain had inclusions in the tongue and developed pneumonia.
The only tortoise infected with a TeHV1 strain had pneumonia, tracheitis and hepatic lipidosis.
Inclusions were seen only in the lung (Table 1).
Fig 8. DNA polymerase-based phylogenetic analysis.Maximum likelihood tree inferred from the partial amino acid sequence of the DNA polymerase of
the 15 investigated TeHVs strains and of the reference strains TeHV2, TeHV4, ChHV5, ChHV6 and Gallid herpesvirus 1 (GaHV1) that served as the
outgroup. (Genbank accession numbers: TeHV1-AB047545.1, TeHV2-AY916792.1, TeHV3 (1976/96 = US1976/98) DQ343881, TeHV4-GQ222415.1,
ChHV5-AF239684.2, ChHV6-EU006876.1, GaHV1- AF168792.1. No accession numbers could be obtained for the partial DNA polymerase protein
sequences generated for the novel detected herpesvirus strains because their length was shorter than the minimum accepted by Genbank).
doi:10.1371/journal.pone.0134897.g008
TeHV3 genome and host-pathogen interaction
PLOS ONE | DOI:10.1371/journal.pone.0134897 August 5, 2015 22 / 32
Fig 9. Glycoprotein B-based phylogenetic analysis.Maximum likelihood tree inferred from the partial aa sequence of the gB of the 15 TeHVs strains
investigated in this study and of reference strains of other ChHV (ChHV5, -6). Gallid herpesvirus 1 (GaHV1) was included as outgroup. Bootstrap values from
500 iterations are shown. This analysis reveals the existence of at least two distinct genogroups within the TeHV3 genotype (A-green boxed and B-red
boxed). A third putative genogroup (C-blue boxed) composed of a single strain is also observed. A TeHV1 strain (IT13/08) clusters within the A genogroup of
the TeHV3 genotype. Clear separation of the TeHV3 genogroups from the sequences of other two chelonian herpesviruses (ChHV5 and ChHV6) is
observed. (Genbank accession numbers: CH1970/02-KP979727, CH1690/03-KP979726, CH1611/07-KP979721, CH2360/06-KP979725, CH2053/
01-KP979723, CH5132/08-KP979729, CH7204/00-KP979719, CH6883/03-KP979730, CH2313/07-KP979722, CH3429/01-KP979720, CH1458/
12-KP979718, US1976/98-KP979717, IT186/12-KP979728, IT191/12-KP979716, IT13/08-KP979724, ChHV5-AAU93326, ChHV6-AAM95776,
GaHV1-YP_182356).
doi:10.1371/journal.pone.0134897.g009
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Phylogeography of TeHV3 genogroups in Switzerland
The distribution of the infected tortoises from Switzerland was closely examined given that
they were the most numerous and representative group. Fig 12 summarizes the locations of the
tortoises infected with different TeHV3 strains. Tortoises infected with either genogroups A or
B or the recombinant strain (C) were already present on the Swiss territory in 2000/2001 and
additional cases of tortoises infected with either A or B genogroups were observed during the
following years, at least up to 2008. In contrast, no additional infections with the recombinant
TeHV3 strain were recorded (Fig 12).
Discussion
The main goal of this research project was to fill a major gap concerning the biology of one of
the most relevant viruses of reptiles, thereby providing new data to further investigate and
Fig 10. Glycoprotein B hypervariable region-based phylogenetic tree. The phylogenetic analysis (Maximum likelihood tree) based on the hypervariable
region of the glycoprotein B gene unambiguously identifies two main genogroups (A-green boxed and B-red boxed) and a third minor one (C) (blue boxed)
within the TeHV3 genotype (Genbank accession numbers: CH1970/02-KP979727, CH1690/03-KP979726, CH1611/07-KP979721, CH2360/06-KP979725,
CH2053/01-KP979723, CH5132/08-KP979729, CH7204/00-KP979719, CH6883/03-KP979730, CH2313/07-KP979722, CH3429/01-KP979720, CH1458/
12-KP979718, US1976/98-KP979717, IT186/12-KP979728, IT191/12-KP979716, IT13/08-KP979724).
doi:10.1371/journal.pone.0134897.g010
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better understand host-pathogen interactions in chelonians. This first example of a de novo
assembly of a chelonian herpesvirus revealed that the TeHV3 genome shares several common
features with other known Alphaherpesvirinae including length, gene-content and overall
arrangement.
The only other chelonian herpesvirus genome available to date is that of ChHV5. The two
genomes share the overall arrangement and show the most similarities within the UL region.
This is consistent with the findings of Alba et al. (2001) [55], with the most conserved gene
blocks in the Herpesviridae spanning from the UL5 to the UL39 homologues. Despite the simi-
larities between the two chelonian virus genomes, interesting differences were identified. For
Fig 11. Glycoprotein B (full sequence)/based phylogenetic analysis.Maximum likelihood tree inferred from the full-length aa sequence of the gB of 2
strains of the TeHV3 and of 35 additional herpesviruses. Bootstrap values from 500 iterations are shown. This analysis shows unambiguous clustering of the
TeHV3main genogroups (A and B) within the Alphaherpesvirinae subfamily in close association with ChHV5 member of the novel identified genus of the
Scutavirus. (Genbank accession numbers: Chelonian HV5-ChHV5-AAU93326, Chelonian HV6-ChHV5-AAM95776, Bovine HV5-BoHV5-YP_003662497.1,
Bovine HV1-BoHV1-NP_045331.1, Suid HV1-SuHV1-YP_068330.1, Feline HV1-FeHV1-YP_003331552.2, Equine HV4-EqHV4-NP_045250.1, Equine
HV9-EqHV9-YP_002333514.1, Equine HV1-EqHV1-YP_053078.1, Cercopithecine HV9-CeHV9-NP_077446.1, Human HV3-HHV3-NP_040154.2,
Saimirine HV1-SaHV1-YP_003933812.1, Cercopithecine HV2-CeHV2-YP_164470.1, Macacine HV1-McHV1-NP_851887.1, Human
HV1-HHV1-NP_044629.1, Human HV2-HHV2-NP_044497.1, Meleagrid HV1-MeHV1-NP_073321.1, Gallid HV3-GaHV3-NP_066859.1, Gallid
HV2-GaHV2-YP_001033956.1, Gallid HV1-GaHV1-YP_182356.1, Testudinid HV3-TeHV3-CH6883/03-KP979730, Testudinid HV3-TeHV3-US1976/
98-KP979717; Cercopithecine HV5-CeHV5-YP_004936031.1, Macacine HV3-McHV3-YP_068182.1, Human HV5-HHV5-YP_081514.1, Saimirine
HV3-SaHV3-YP_004940228.1, Human HV7-HHV7-YP_073779.1, Human HV6A-HHV6A-NP_042932.1, Human HV6B-HHV6B-NP_050220.1, Human
HV4-HHV4-YP_001129508.1, Macacine HV4-McHV4-YP_068009.1, Equine HV2-EqHV2-NP_042604.1, Ovine HV2-OvHV2-YP_438135.1, Saimirine
HV2-SaHV2-NP_040210.1, Bovine HV4-BoHV4-NP_076500.1, Human HV8-HHV8-YP_00119354.1, Macacine HV5-McHV5-NP_570749.1).
doi:10.1371/journal.pone.0134897.g011
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example the two genomes appear to differ by approximately 18 Kb in length, with ChHV5 lack-
ing several genes that were identified in TeHV3 [22]. The missing genes encode for proteins
that apparently are dispensable for viral growth in vitro [22]. Among these are UL 46, 47, 48,
49.2, 49.5 and 51, which encode for structural elements such as tegument proteins. The absence
of these genes might be compensated by other genes with similar functions that are present in
the ChHV5 genome. However, other genes present in TeHV3 and absent in ChHV5 might
have more critical roles for TeHV3. These include genes encoding for enzymes such as sero-
nine-threonine kinase (UL13) that is likely relevant for intracellular signaling and cell cycling,
and a dUTP diphosphatase (UL50), which together with the small subunit of the ribonucleo-
tide reductase (UL40) and the thymidylate synthetase (UL45) are important for de novo syn-
thesis of DNA. UL 54 encodes for the homologous gene of HSV1 ICP27 a potent gene
transactivator. Additionally, the lack of UL44 homologous gene encoding for the glycoprotein
C (gC) in ChHV5 in comparison to TeHV3 might be critical for immune evasion. Glycoprotein
C is known to bind to C3 and to inhibit virus neutralization [53]. The overall functional impli-
cations associated with the presence or absence of these genes in TeHV3 and ChHV5,
Fig 12. TeHV3 phylogeography (Switzerland).Green dots show the geographic origin of the tortoises infected with TeHV3 genogroup A, whereas red dots
correspond to the geographic origin of the tortoises infected with TeHV3 genogroup B. The blue dot shows the location of the only tortoise infected with the
recombinant strain originated from putative homologous recombination between a strain from the genogroup A and one from the genogroup B. The year next
to the respective color dot correspond to the time when the specific tortoise died of TeHV3 infection. Main borders of Switzerland and of the Swiss cantons
are also shown in the figure along with the main lakes (http://d-maps.com/carte.php?num_car=24787&lang = de).
doi:10.1371/journal.pone.0134897.g012
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respectively, are difficult to predict without the appropriate investigations. However, the lack
of genes encoding for proteins relevant for the de novo synthesis of viral DNA and subse-
quently for viral replication, together with that of a major immediate early gene such as the
homologue of ICP27 might help to explain some of the different features of TeHV3 and
ChHV5, including for example the failure to grow ChHV5 in cell culture or the distinct patho-
logical changes caused by these two viruses: necrotizing lesions in tortoises infected with
TeHV3 and proliferative lesions of neoplastic nature in sea turtles infected with ChHV5. Fur-
ther in vitro and in vivo studies are necessary to explore the functional bases for these
differences.
The differences in gene content of TeHV3 and ChHV5 may be secondary to differences in
co-evolution that might have occurred with their respective hosts. Chelonians are a group of
vertebrates that has evolved into multiple families that have diverged over millions of years
[56], with adaptations to very different environments such as dry land and oceans. The genus
Testudo comprises several species commonly infected by TeHV3. This genus is part of the fam-
ily Testudinidae, which includes tortoises, dry land chelonians whose appearance in the fossil
record dates back to the late Cretaceous [57]. Tortoises of the genus Testudo are considered to
have originated in the African continent and later spread into Europe [56]. Cheloniidae is one
of the two families of sea turtles having members susceptible to infection with ChHV5. Of the
Cheloniidae, Chelonia mydas and Caretta caretta are two species of sea turtles most commonly
infected by ChHV5. Their ancestors, the Americhelydae are believed to have originated in the
North American continent during the Cretaceous [58], whereas their presence in the Mediter-
ranean is considered to be more recent and occurred probably no more than 12,000 years ago
[59]. No detection of ChHV5 has been yet reported in Mediterranean sea turtles. This suggests
that it is unlikely that TeHV3 and ChHV5 might have diverged recently from a hypothetical
common ancestor consistently with the results of the genome comparison (Fig 2). The pre-
sumptive long-standing independent co-evolution of the two viruses with hosts with distinct
anatomical and physiological adaptations to their native habitats, may partially account for the
different content in genes between TeHV3 and ChHV5. More sequencing data including that
of TeHV2, the only North American TeHV genotype known to date are needed to contribute
to better understand the actual correlation and evolutionary relationships between Testudinid
herpesviruses and ChHV5. Finally, the presence in TeHV3 (and the absence in ChHV5) of the
homologous gene of UL45, which encodes for the thymdylate synthetase gene present only in
HHV3-VZV among the Alphaherpesvirinae but common in Gammaherpesvirinae was an
interesting finding. However, despite this common feature with a Varicellovirus, TeHV3 does
not appear to cluster in this genus. Furthermore, TeHV3 clusters closely to ChHV5, a
Scutavirus.
The novel genomic information described in this report is considered an important step to
further illuminate the host-pathogen interactions in chelonians. The sequencing of the TeHV3
genome has allowed for the identification of several homologous genes to those of well-charac-
terized herpesviruses. Among these, the gB gene is one of the most critical genes for herpesvirus
infectivity given the role of its encoded protein in cell entry [39, 40]. Furthermore, gB is both
relatively well conserved among herpesviruses and at the same time it is under a likely higher
evolutionary pressure than the DNApol because of the direct pressure exerted by the host
immune system eliciting the production of neutralizing antibodies [40]. These features con-
vinced us to select the gB gene sequence (and translated aa sequence) as an ideal phylogenetic
marker to attempt to increase the phylogenetic resolution power among the TeHV3 strains
and potentially trace correlations between distinct TeHV3 genogroups and pathology pheno-
types in tortoises. The phylogenetic analysis performed with the partial sequence of gB, showed
unambiguously the existence of at least two distinct genogroups of TeHV3 strains, named A
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and B, respectively, which could not be detected when using the partial DNA pol sequence.
The phylogenetic analysis performed on a highly variable region of the gB gene further
highlighted this distinction. The localization of four of the five missense substitutions spanning
across a relatively central portion of the gene (1521-1845nt; Figs 5 and 6) is of interest given
that it does not have a correspondence in the homologue gene of the type species of Alphaher-
pesvirinae, HSV1. Comparing different HSV1 gB aa sequences (data not shown), aa changes
occur either within the very proximal N- and C-portion of the protein. The crystal structure of
HSV1 gB has recently become available and antigenic and mutational analysis suggests that
several domains spanning for most of the length of the protein ectodomain are required for
virus entry [39]. The different clustering of aa changes occurring in TeHV3 gB might suggest a
different arrangement of the most functionally relevant domains of TeHV3 gB than the
HSV1’s homologue. Similar distribution of the missense mutations is observed in ChHV5
strains. However, the specific functions of the different HSV1’s gB domains are not yet fully
understood and more investigations are needed to understand potential functional differences
between HSV1’s and TeHV3 gB.
Most of the identified strains in the fatally infected tortoises investigated in this study
belonged to group A and a smaller number clustered within group B, possibly suggesting that
subgroup A is the most common of the two genogroups. However, a large sample size is neces-
sary to clarify this point. A distinct third group (C), which was identified in a single tortoise,
was shown to be the result of homologous recombination between members of the A and B
genogroups consistent with co-infection of tortoises with both TeHV3 genogroups. To the best
of our knowledge this is the first example of homologous recombination demonstrated in a
chelonian herpesvirus and the first indirect example of multiple TeHV3 strain infection in tor-
toises. The gB-based phylogenetic analysis (either with aa or nt sequences) clustered the only
detected TeHV1 strain together with TeHV3 genogroup A, suggesting that the phylogenetic
relationships between distinct TeHVs might be more complex than previously considered and
might be influenced also by homoplasy. Consequently, our novel genotyping method is com-
plementary to the one based on the DNA pol, and we recommend for a more thorough and
precise TeHVs characterization the following hierarchical approach: 1) identification of the
TeHV genotype by sequencing of the partial DNA pol gene [33] and 2) identification of the
TeHV3 genogroups based on the gB gene sequence.
Within the limitations associated with the small sample size, we observed differences
between the pathology phenotype associated with TeHV3 genogroups A and B infection. Spe-
cifically, TeHV3 genogroup B infection was associated with more frequent occurrence of intra-
nuclear inclusions, viral pneumonia, vasculitis or perivasculitis and changes in the CNS than
with TeHV3 genogroup A infection. These findings are suggesting of the existence of at least
two subgroups of Testudinid herpesvirus responsible for different pathology. The putative
recombinant strain between A and B subgroups showed intermediate pathogenicity between
the two. However, since this is based on a single isolate, further isolates need to be studied to
confirm this observation. A transmission study carried out with both TeHV3 genogroups will
be necessary to confirm the observations described above.
An important contribution of this investigation is the indirect assessment of some anecdotal
observations reported by veterinarians and tortoise breeders; which include tortoises develop-
ing clinical signs of herpesvirus infection primarily in the spring or late fall. These observations
support circumstantial reports from veterinarians and tortoise breeders that die-offs of tor-
toises secondary to TeHVs infection mostly occur after the end or just prior to hibernation.
Furthermore, a presumptive different sensitivity of different species of tortoises to TeHV infec-
tion and/or disease has been suggested for the Mediterranean Hermann’s and Greek tortoise
[14]. Consistently, Hermann’s tortoises were overrepresented in our study group suggesting
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that this species is more sensitive to TeHV3. Further work is needed to substantiate these
findings.
In conclusion, we have successfully performed the first complete de novo assembly of a che-
lonian herpesvirus, providing fundamental genetic information to obtain greater insight into
the biology of this virus and the host-pathogen interaction in an early diverging vertebrate line-
age. This enabled us to identify at least two distinct subgroups of the TeHV3 genotype and the
distinct lesional profiles caused by these viruses in the tortoises examined in this study. This
unearths new foundations for future studies on host-parasite resistance and infection.
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